Efficacy and safety of the combination of aflibercept with fluorouracil, leucovorin, and irinotecan in patients aged 70 years and older with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen in Spain: A retrospective multicenter cohort study.

Laura Gutiérrez Sainz,Sergio Martínez-Recio,Oliver Higuera,Ismael Ghanem,Ana López-Alfonso,Mar Pérez,Ana María Jiménez Gordo,Miriam López-Gómez,Raquel Molina,Patricia Ibeas,Jaime Feliu,N Rodríguez Salas

Efficacy and safety of the combination of aflibercept with fluorouracil, leucovorin, and irinotecan in patients aged 70 years and older with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen in Spain: A retrospective multicenter cohort study.

2020

Laura Gutiérrez Sainz
Sergio Martínez-Recio
Oliver Higuera
Ismael Ghanem
Ana López-Alfonso
Mar Pérez
Ana María Jiménez Gordo
Miriam López-Gómez
Raquel Molina
Patricia Ibeas
Jaime Feliu
N Rodríguez Salas

124Background: Colorectal cancer is currently the third most common cancer worldwide. The results of the VELOUR study showed that the addition of aflibercept to Fluorouracil, Leucovorin, and Irinot...

Keywords:

Irinotecan
Fluorouracil
Internal medicine
Oxaliplatin
Medicine
Aflibercept
Colorectal cancer
Oncology
Regimen
Cohort study
Pathology
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations